Skip to main content

(Approval lapsed 22/6/2020) Phenelzine Sulfate USP 15mg tablets (Lupin Pharmaceuticals)

Section 19A approved medicine
(Approval lapsed 22/6/2020) Phenelzine Sulfate USP 15mg tablets (Lupin Pharmaceuticals)
Section 19A approval holder
Medsurge Healthcare Pty Ltd ABN 92 124 728 892
Phone
1300 788 261
Approved until
Status
Lapsed
Medicines in short supply/unavailable
NARDIL phenelzine 15mg (as sulfate) tablet bottle - ARTG 93600
Indication(s)

For the treatment of depression. Phenelzine Sulfate Tablets should rarely be the first antidepressant drug used. Rather, it is more suitable for use with patients who have failed to respond to the drugs more commonly used for these conditions.

Additional information

Approval lapsed at sponsor's request

Help us improve the Therapeutic Goods Administration site